Eton Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ETON, and when can generic versions of ETON drugs launch?
ETON has three approved drugs.
There are three US patents protecting ETON drugs.
There are forty-six patent family members on ETON drugs in twenty-five countries and five supplementary protection certificates in three countries.
Summary for Eton
International Patents: | 46 |
US Patents: | 3 |
Tradenames: | 3 |
Ingredients: | 3 |
NDAs: | 3 |
Patent Litigation for Eton: | See patent lawsuits for Eton |
PTAB Cases with Eton as petitioner: | See PTAB cases with Eton as petitioner |
Drugs and US Patents for Eton
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-002 | Sep 29, 2020 | RX | Yes | No | 9,649,280 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-001 | Sep 29, 2020 | RX | Yes | No | 9,649,280 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-003 | Sep 29, 2020 | RX | Yes | No | 9,717,740 | ⤷ Subscribe | ⤷ Subscribe | ||||
Eton | NITISINONE | nitisinone | CAPSULE;ORAL | 216201-003 | May 25, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Eton Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 112014011745 | ⤷ Subscribe |
Cyprus | 1123284 | ⤷ Subscribe |
South Korea | 102219919 | ⤷ Subscribe |
Spain | 2782503 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Eton Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0591275 | 05C0024 | France | ⤷ Subscribe | PRODUCT NAME: NITISINONE; REGISTRATION NO/DATE: EU/1/04/303/001 20050221 |
0591275 | C300198 | Netherlands | ⤷ Subscribe | PRODUCT NAME: NITISINONE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR DBAAR ZOUT; REGISTRATION NO/DATE: EU/1/04/303/001-003 20050201 |
0591275 | SPC/GB05/030 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: NITISINONE (2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-1,3-CYCLOHEXANEDIONE) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/303/001 20050221; UK EU/1/04/303/002 20050221; UK EU/1/04/303/003 20050221 |
0809498 | SPC/GB10/012 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.